Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets
Stahl M, Goldberg A. Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: Novel Combinations and Therapeutic Targets. Current Oncology Reports 2019, 21: 37. PMID: 30904967, DOI: 10.1007/s11912-019-0781-7.Peer-Reviewed Original ResearchConceptsAcute myeloid leukemiaImmune checkpoint inhibitionImmune checkpoint inhibitorsCheckpoint inhibitorsCheckpoint inhibitionHypomethylating agentsMyeloid leukemiaCombination of immune checkpoint inhibitionSuccess of immune checkpoint inhibitionClinical trialsEarly-phase clinical trialsCheckpoint inhibitor monotherapyMultiple clinical trialsCheckpoint therapyImmune checkpointsInhibitor monotherapyStandard therapySolid malignanciesImmune targetsTherapeutic efficacyClinical activityTherapeutic landscapeLeukemiaTherapeutic targetLeukemia cells
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply